United States · 
Who invested in Candel Therapeutics?
Candel Therapeutics's investors include Northpond Ventures, SANDS, Level One Fund and H7 Ventures. Northpond Ventures led its latest round.
United States · Series C startup
Who invested in Candel Therapeutics
Funding summaryUpdated 26 Oct 2026
$23Mraised across 1 round since 2019, from 1 source
- Latest round
- Series C, $23MApr 2019
- Led by
- Northpond Ventures
- Investors
- 4 (1 led)
The rounds
- Apr 2019
Founders and team
From Candel Therapeutics's own website: 6 on the team.
- Charles SchochChief Financial Officer
- Ileen WinickChief People Officer
- Mark SimsChief Commercial Officer
- Harvard Medical SchoolJerome and Nancy Kohlberg Emeritus Chair in Medicine
- Memorial Sloan Kettering Cancer CenterJerome and Nancy Kohlberg Emeritus Chair in Medicine
- Paul B. ManningChair of the Board
Everyone who backed them
H7 VenturesVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Candel Therapeutics
How much has Candel Therapeutics raised?
Candel Therapeutics has raised $23M across 1 round since 2019.
When did Candel Therapeutics last raise?
Candel Therapeutics's most recent round was a Series C of $23M in Apr 2019, led by Northpond Ventures.
What was Candel Therapeutics's biggest round?
Its most recent round, $23M in Apr 2019, is also its largest on record.
Who backed Candel Therapeutics first?
Candel Therapeutics's first round on record, in Apr 2019, was backed by Northpond Ventures, SANDS and Level One Fund and 1 others.
What stage is Candel Therapeutics at?
Candel Therapeutics's latest named round is a Series C, in Apr 2019.
Where is Candel Therapeutics based?
Candel Therapeutics is based in the United States.
Who led Candel Therapeutics's rounds?
Northpond Ventures led the Series C in 2019.
Companies like Candel Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.